---
title: "A SPAC II ACQUISITION CORP C/WTS 15/10/2026 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/266434258.md"
datetime: "2025-11-18T21:08:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266434258.md)
  - [en](https://longbridge.com/en/news/266434258.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266434258.md)
generator: "portal-rs"
---

# A SPAC II ACQUISITION CORP C/WTS 15/10/2026 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 0

Revenue: As of FY2025 Q3, the actual value is USD 0.

EBIT: As of FY2025 Q3, the actual value is USD -100.28 K.

### Operational Metrics

-   **General and Administrative Expenses**: For the three months ended September 30, 2025, expenses were $78,428, compared to $195,662 for the same period in 2024. For the nine months ended September 30, 2025, expenses were $251,961, compared to $497,763 for the same period in 2024.
-   **Net Loss**: For the three months ended September 30, 2025, the net loss was $56,580, compared to a net loss of $64,743 for the same period in 2024. For the nine months ended September 30, 2025, the net loss was $134,658, compared to a net income of $215,882 for the same period in 2024.

### Cash Flow

-   **Operating Activities**: Cash used in operating activities for the nine months ended September 30, 2025, was $313,564, compared to $369,395 for the same period in 2024.
-   **Investing Activities**: Cash provided by investing activities for the nine months ended September 30, 2025, was $4,078,485, compared to $18,165,082 for the same period in 2024.
-   **Financing Activities**: Cash used in financing activities for the nine months ended September 30, 2025, was $3,855,269, compared to $18,165,082 for the same period in 2024.
-   **Cash Balance**: As of September 30, 2025, the cash balance was $50,633, compared to $140,981 as of December 31, 2024.

### Unique Metrics

-   **Interest Income**: For the three months ended September 30, 2025, interest income was $21,848, compared to $130,919 for the same period in 2024. For the nine months ended September 30, 2025, interest income was $117,303, compared to $713,645 for the same period in 2024.

### Future Outlook and Strategy

#### Core Business Focus

-   The company plans to complete its initial Business Combination using various financial instruments, including cash from the IPO and private placement warrants, by August 5, 2027.

#### Non-Core Business

-   The company has an extension to pursue a business combination with entities primarily operating in China, including Hong Kong and Macau.

#### Priority

-   The company anticipates incurring significant professional and transaction costs to remain publicly traded and pursue a business combination, requiring additional financing. There is no assurance of successful capital raising, and failure to consummate a Business Combination by August 5, 2027, will result in automatic winding up, dissolution, and liquidation.

### Related Stocks

- [ASCWF.US](https://longbridge.com/en/quote/ASCWF.US.md)

## Related News & Research

- [Oil set for second weekly rise as unsettled US-Iran war crimps supply](https://longbridge.com/en/news/296555193.md)
- [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md)
- [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md)
- [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md)
- [Broadcom Stabilizes After Google's $120 Billion Marvell Shock](https://longbridge.com/en/news/296529317.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**